Dr Reddy's Laboratories Q4 Results
- BSE: 500124
- NSE: DRREDDY
- ISIN: INE089A01031
- Sector: Biotechnology & Drugs
BSE
1,268
-6.55 (-0.51%)
-6.55 (-0.51%)Volume17.31 K
Updated: Fri 13 Feb, 2026 | 15:25:51
NSE
1,268.10-6.80 (-0.53%)
-6.80 (-0.53%)Volume8.39 L
Updated: Fri 13 Feb, 2026 | 15:40:05
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 25
Note: Comparison is on QoQ basis
Quarterly - Dr Reddy's Laboratories Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 6,944.70 | 7,386.90 | 5.55% | 5,648.70 | 22.94% |
| Depreciation/ Amortization | 454.70 | 521.00 | -3.54% | 367.70 | 23.66% |
| Operating Income | 1,583.70 | 1,366.50 | -12.09% | 1,465.10 | 8.10% |
| Net Income | 1,593.30 | 1,209.90 | 12.70% | 1,309.80 | 21.64% |
| Other Operating Expenses Total | 2,162.60 | 2,155.10 | N/A | - | N/A |
| Net Income Before Taxes | 2,005.20 | 1,543.20 | 6.98% | 1,605.20 | 24.92% |
| Total Revenue | 8,528.40 | 8,753.40 | 1.76% | 7,113.80 | 19.89% |
| Selling/ General/ Admin Expenses Total | 1,400.60 | 1,588.50 | -60.29% | 3,206.20 | -56.32% |
| Diluted Normalized EPS | 19.83 | 14.77 | 17.09% | 15.53 | 27.66% |